Literature DB >> 25993447

Paw-dragging: a novel, sensitive analysis of the mouse cylinder test.

R Brian Roome1, Jacqueline L Vanderluit2.   

Abstract

The cylinder test is routinely used to predict focal ischemic damage to the forelimb motor cortex in rodents. When placed in the cylinder, rodents explore by rearing and touching the walls of the cylinder with their forelimb paws for postural support. Following ischemic injury to the forelimb sensorimotor cortex, rats rely more heavily on their unaffected forelimb paw for postural support resulting in fewer touches with their affected paw which is termed forelimb asymmetry. In contrast, focal ischemic damage in the mouse brain fails to result in comparable consistent deficits in forelimb asymmetry. While forelimb asymmetry deficits are infrequently observed, mice do demonstrate a novel behaviour post stroke termed "paw-dragging". Paw-dragging is the tendency for a mouse to drag its affected paw along the cylinder wall rather than directly push off from the wall when dismounting from a rear to a four-legged stance. We have previously demonstrated that paw-dragging behaviour is highly sensitive to small cortical ischemic injuries to the forelimb motor cortex. Here we provide a detailed protocol for paw-dragging analysis. We define what a paw-drag is and demonstrate how to quantify paw-dragging behaviour. The cylinder test is a simple and inexpensive test to administer and does not require pre-training or food deprivation strategies. In using paw-dragging analysis with the cylinder test, it fills a niche for predicting cortical ischemic injuries such as photothrombosis and Endothelin-1 (ET-1)-induced ischemia--two models that are ever-increasing in popularity and produce smaller focal injuries than middle cerebral artery occlusion. Finally, measuring paw-dragging behaviour in the cylinder test will allow studies of functional recovery after cortical injury using a wide cohort of transgenic mouse strains where previous forelimb asymmetry analysis has failed to detect consistent deficits.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25993447      PMCID: PMC4541598          DOI: 10.3791/52701

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

1.  The "staircase test": a measure of independent forelimb reaching and grasping abilities in rats.

Authors:  C P Montoya; L J Campbell-Hope; K D Pemberton; S B Dunnett
Journal:  J Neurosci Methods       Date:  1991-02       Impact factor: 2.390

2.  Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats.

Authors:  Bryan Kolb; Cindi Morshead; Claudia Gonzalez; Mina Kim; Christopher Gregg; Tetsuro Shingo; Samuel Weiss
Journal:  J Cereb Blood Flow Metab       Date:  2006-09-20       Impact factor: 6.200

3.  AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke.

Authors:  Andrew N Clarkson; Justine J Overman; Sheng Zhong; Rudolf Mueller; Gary Lynch; S Thomas Carmichael
Journal:  J Neurosci       Date:  2011-03-09       Impact factor: 6.167

4.  An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat.

Authors:  Victoria Windle; Aleksandra Szymanska; Shirley Granter-Button; Chistopher White; Richard Buist; James Peeling; Dale Corbett
Journal:  Exp Neurol       Date:  2006-06-05       Impact factor: 5.330

5.  Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender.

Authors:  Xiaoling Li; Kathleen K Blizzard; Zhiyuan Zeng; A Courtney DeVries; Patricia D Hurn; Louise D McCullough
Journal:  Exp Neurol       Date:  2004-05       Impact factor: 5.330

6.  Quantitative and qualitative impairments in skilled reaching in the mouse (Mus musculus) after a focal motor cortex stroke.

Authors:  Tracy D Farr; Ian Q Whishaw
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

7.  Neurogenesis associated with endothelin-induced cortical infarction in the mouse.

Authors:  Yaoming Wang; Kunlin Jin; David A Greenberg
Journal:  Brain Res       Date:  2007-07-17       Impact factor: 3.252

8.  Two effective behavioral tasks for evaluating sensorimotor dysfunction following traumatic brain injury in mice.

Authors:  Yelena K Baskin; W Dalton Dietrich; Edward J Green
Journal:  J Neurosci Methods       Date:  2003-10-15       Impact factor: 2.390

9.  A qualitative and quantitative analysis of skilled forelimb reaching impairment following intracerebral hemorrhage in rats.

Authors:  Jared Clarke; Michelle Ploughman; Dale Corbett
Journal:  Brain Res       Date:  2007-02-08       Impact factor: 3.252

10.  Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke.

Authors:  Andrew N Clarkson; Ben S Huang; Sarah E Macisaac; Istvan Mody; S Thomas Carmichael
Journal:  Nature       Date:  2010-11-03       Impact factor: 49.962

View more
  12 in total

1.  Nogo-A targeted therapy promotes vascular repair and functional recovery following stroke.

Authors:  Ruslan Rust; Lisa Grönnert; Christina Gantner; Alinda Enzler; Geertje Mulders; Rebecca Z Weber; Arthur Siewert; Yanuar D P Limasale; Andrea Meinhardt; Michael A Maurer; Andrea M Sartori; Anna-Sophie Hofer; Carsten Werner; Martin E Schwab
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

2.  Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration.

Authors:  Christine M Rostosky; Ira Milosevic
Journal:  J Vis Exp       Date:  2018-06-18       Impact factor: 1.355

3.  The Spinal Transcriptome after Cortical Stroke: In Search of Molecular Factors Regulating Spontaneous Recovery in the Spinal Cord.

Authors:  Julia Kaiser; Martina Maibach; Iris Salpeter; Niels Hagenbuch; Vladimir B C de Souza; Mark D Robinson; Martin E Schwab
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

4.  Front and hind paw differential analgesic effects of amitriptyline, gabapentin, ibuprofen, and URB937 on mechanical and cold sensitivity in cisplatin-induced neuropathy.

Authors:  Jeremy M Thompson; Henry L Blanton; Agata Pietrzak; William Little; Caitlyn Sherfey; Josée Guindon
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

5.  TGFβ1 Induces Axonal Outgrowth via ALK5/PKA/SMURF1-Mediated Degradation of RhoA and Stabilization of PAR6.

Authors:  Julia Kaiser; Martina Maibach; Ester Piovesana; Iris Salpeter; Nora Escher; Yannick Ormen; Martin E Schwab
Journal:  eNeuro       Date:  2020-09-29

6.  Detection of locomotion deficit in a post-traumatic syringomyelia rat model using automated gait analysis technique.

Authors:  Dipak D Pukale; Mahmoud Farrag; Nic D Leipzig
Journal:  PLoS One       Date:  2021-11-11       Impact factor: 3.240

7.  ROS-responsive 18β-glycyrrhetic acid-conjugated polymeric nanoparticles mediate neuroprotection in ischemic stroke through HMGB1 inhibition and microglia polarization regulation.

Authors:  Lulu Jin; Zhixin Zhu; Liangjie Hong; Zhefeng Qian; Fang Wang; Zhengwei Mao
Journal:  Bioact Mater       Date:  2022-04-01

Review 8.  Behavioral Assessment of Sensory, Motor, Emotion, and Cognition in Rodent Models of Intracerebral Hemorrhage.

Authors:  Xiaoyu Shi; Huiying Bai; Junmin Wang; Jiarui Wang; Leo Huang; Meimei He; Xuejun Zheng; Zitian Duan; Danyang Chen; Jiaxin Zhang; Xuemei Chen; Jian Wang
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

9.  Light-Emitting Diode Photobiomodulation After Cerebral Ischemia.

Authors:  Bárbara Argibay; Francisco Campos; María Perez-Mato; Alba Vieites-Prado; Clara Correa-Paz; Esteban López-Arias; Andrés Da Silva-Candal; Vicente Moreno; Carlos Montero; Tomás Sobrino; José Castillo; Ramón Iglesias-Rey
Journal:  Front Neurol       Date:  2019-08-22       Impact factor: 4.003

10.  Acute motor deficit and subsequent remyelination-associated recovery following internal capsule demyelination in mice.

Authors:  Reiji Yamazaki; Nobuhiko Ohno; Jeffrey K Huang
Journal:  J Neurochem       Date:  2020-08-14       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.